Literature DB >> 32712303

Proteomics in thyroid cancer and other thyroid-related diseases: A review of the literature.

Yasemin Ucal1, Aysel Ozpinar2.   

Abstract

Misdiagnosis, over-diagnosis, or inappropriate treatment strategies are frequently seen in thyroid disease management. Currently, there is an urgent interest to identify biomarkers for specific disease states in the thyroid gland. Proteomics-based approaches have been widely used for the discovery of potential biomarkers in thyroid research. Specifically, proteomic techniques have been used to better understand thyroid tumors of different origin and classification. Besides, there is remarkable thyroid proteomics research in thyroid-related diseases, including thyroid orbitopathy. In this review, we aim to describe proteomic studies and how the results obtained from thyroid cancer, up to now, as well as those from, other thyroid-related diseases pose challenges, which might be solved via high-resolution protein analysis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer proteomics; Proteomics; Thyroid cancer; Thyroid orbitopathy

Year:  2020        PMID: 32712303     DOI: 10.1016/j.bbapap.2020.140510

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  3 in total

Review 1.  Putting Proteomics Into Immunotherapy for Glioblastoma.

Authors:  Liangyu Chen; Di Qin; Xinyu Guo; Qixue Wang; Jie Li
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

2.  Comprehensive analysis of tissue proteomics in patients with papillary thyroid microcarcinoma uncovers the underlying mechanism of lymph node metastasis and its significant sex disparities.

Authors:  Zhen Cao; Zejian Zhang; Xiaoyue Tang; Rui Liu; Mengwei Wu; Jianqiang Wu; Ziwen Liu
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

3.  Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma N-Glycomics.

Authors:  Zejian Zhang; Karli R Reiding; Jianqiang Wu; Zepeng Li; Xiequn Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.